Correction: Continuing a cancer treatment despite tumor growth may be valuable: Sunitinib in renal cell carcinoma as example

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117539/
http://dx.doi.org/10.1371/journal.pone.0105179
_version_ 1782328716598181888
collection PubMed
description
format Online
Article
Text
id pubmed-4117539
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-41175392014-08-04 Correction: Continuing a cancer treatment despite tumor growth may be valuable: Sunitinib in renal cell carcinoma as example PLoS One Correction Public Library of Science 2014-07-31 /pmc/articles/PMC4117539/ http://dx.doi.org/10.1371/journal.pone.0105179 Text en © 2014 The PLOS ONE Staff http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Correction
Correction: Continuing a cancer treatment despite tumor growth may be valuable: Sunitinib in renal cell carcinoma as example
title Correction: Continuing a cancer treatment despite tumor growth may be valuable: Sunitinib in renal cell carcinoma as example
title_full Correction: Continuing a cancer treatment despite tumor growth may be valuable: Sunitinib in renal cell carcinoma as example
title_fullStr Correction: Continuing a cancer treatment despite tumor growth may be valuable: Sunitinib in renal cell carcinoma as example
title_full_unstemmed Correction: Continuing a cancer treatment despite tumor growth may be valuable: Sunitinib in renal cell carcinoma as example
title_short Correction: Continuing a cancer treatment despite tumor growth may be valuable: Sunitinib in renal cell carcinoma as example
title_sort correction: continuing a cancer treatment despite tumor growth may be valuable: sunitinib in renal cell carcinoma as example
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117539/
http://dx.doi.org/10.1371/journal.pone.0105179
work_keys_str_mv AT correctioncontinuingacancertreatmentdespitetumorgrowthmaybevaluablesunitinibinrenalcellcarcinomaasexample

Ejemplares similares